Levodopa EP Impurity B CAS 60-18-4
| CAS No. | 60-18-4 |
| Molecular Formula | C9H11NO3 |
| Molecular Weight | 181.19 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a process- or degradation-related impurity, Levodopa EP Impurity B (CAS 60-18-4, C9H11NO3) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Owing to an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage, Levodopa EP Impurity B is typically off-white to pale yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 181.19 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Levodopa EP Impurity B under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C9H11NO3 |
| Molecular Weight | 181.19 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (faint amine-like odor) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 5.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1957 |
| Nitrogen Atoms | 1 |
Related Levodopa Standards
Recommended Standards
- Bilirubin impurity 4 (CAS CATO-C4X-15614)
- Ceftizoxime Impurity 39 (CAS 26531-82-8)
- Abacavir Impurity 17 (CAS CATO-C4X-152717)
- Adrenaline Impurity 100 (CAS CATO-C4X-1849100)
- Rosuvastatin Impurity 142 (CAS CATO-C4X-1169142)
- Phloroglucinol impurity 45 (CAS 634-94-6)
- Amlodipine Impurity 42 (CAS 158151-92-9)
- 2-Bromo-4-chloro-6-(chloromethyl)pyridine (CAS 1393550-36-1)
- 1-(3-fluorophenyl)-3-methylpiperazine (CAS 1250098-88-4)
- 1-(2-(1-Benzyl-2-methyl-1H-indol-3-yl)ethyl)-3-phenylthiourea (CAS 332867-80-8)
- 3-(Chloromethyl)-6-methoxyquinolin-2(1H)-one (CAS 90097-81-7)
- (Z)-3-(3,6-Diethylpyrazin-2-yl)acrylonitrile (CAS 108290-51-3)
- (9E,12E,15E)-octadeca-9,12,15-trienoic acid (CAS CATO-C1484970)
- [Ser39-OH] Tirzepatide (CAS CATO-C4X-324041)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com